Alert: The Endocrine Society Statement on the New England Journal of Medicine Letter to the Editor on PTU Use In Children

The Letter to the Editor in this week’s New England Journal of Medicine1 by Dr.’s Rivkees and Mattison highlights concern about potential severe liver disease in children of the commonly used antithyroid drug, propylthiouracil (PTU), an adverse effect...

Alert: Endocrine Society Statement to Providers on NICE-SUGAR

The NICE-SUGAR study, published in today’s New England Journal of Medicine1, reports on mortality in 6000 critically ill hyperglycemic patients patients randomly assigned to either tight control of blood sugar...

Alert: NIH Releases Information on Challenge Grant Application Process

The National Institutes of Health has released information on the Challenge Grant application process.  These Challenge Grants will be funded out of the $10 billion given to the NIH...

Alert: Economic Recovery Compromise Includes Funds for NIH

The House and Senate Conferees met on Wednesday, February 11 to  come to an agreement on differences between the House- and Senate-passed versions of the American Recovery and Reinvestment Act...

Act Now! Senate to Vote on Economic Recovery Package and Research Funds

Thank you to all who responded to our call to action this week by sending a letter to your member of Congress in support of biomedical research funding in the economic recovery package...

Alert: Stop DXA Payment Cuts by Providing Practice Information to TES

As you know, DXA reimbursement in the physician's office (non-facility) setting has been reduced by approximately 50% over the last three years from an average of $140 in 2006 to an average of $71 in 2009...

Alert: House to Vote on NIH Funding – Contact Congress Now!

As reported in Endocrine Insider, the House plans to vote on the Democratic economic stimulus package as early as this Wednesday, January 28th.  If the package passes in its current form, the NIH will receive $1.5 billion for grants...

Alert: EMEA Reconsidering Acomplia Marketing 

The European Medicines Agency (EMEA) has recommended that marketing of Acomplia (rimonabant) be suspended in the Europe Union due to concerns about psychiatric side effects. The EMEA's Committee for Medicinal Products...

The Food and Drug Administration issued a MedWatch alert this week urging physicians to discontinue the use of Byetta in patients suspected to be suffering from pancreatitis. Since October 2007, the FDA has received reports of six cases...

ICD-10 OMB Sign-On Letter 

This letter expresses our deep concerns regarding the U.S. Department of Health and Human Services' (HHS) plan to mandate the rapid implementation of the International Statistical Classification...

GAO Imaging Report Sign-On Letter

The undersigned organizations are writing to provide our views on the findings in the Government Accountability Office (GAO) report, "Medicare Part B Imaging Services -- Rapid Spending Growth..."

Earlier this week, the U.S. Food and Drug Administration announced that EMD Serono has made a business decision to discontinue the manufacture of Geref Diagnostic...